Is liver damage dependent on the serotype of dengue virus? - A study in Mexico

Dengue Bulletin

Volumn 30, Issue , 2006, Pages 114-120

  Vazquez Pichardo M ^a   Rosales Jimenez C ^b   Rojas Espinosa, O ^a   Lopez Martinez I ^b   Moreno Altamirano, M M B ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

Author keywords

Dengue virus; Hepatotoxicity; Paracetamol; Serotype

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; PARACETAMOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE SEVERITY; DRUG INDICATION; DRUG USE; ENDEMIC DISEASE; ENZYME ACTIVITY; FEMALE; HEPATOMEGALY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DISEASE; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; MEXICO; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE;

ANIMALIA; DENGUE VIRUS; MUS;

EID: 34848844433     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002 Feb;10(2):100-3.
2. Guzman MG and Kouri G. Dengue and Dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003 May;27(1):1-13.
3. Halstead SB. Global perspective on dengue research. Dengue Bull 2000;24:77-82.
4. Carlos CC, Oishi K, Cinco MT, Mapua CA, Inoue S, Cruz DJ, Pancho MA, Tanig CZ, Matias RR, Morita K, Natividad FF, Igarashi A, Nagatake T. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg 2005 Aug;73(2):435-40.
5. Halstead SB, Heinz FX, Barret AD, Roehrig JT. Dengue virus: molecular basis of cell entry and pathogenesis. 25-27 June 2003, Vienna, Austria. Vaccine 2005 Jan 4;23(7):849-56.
6. Blaney JE Jr, Matro JM, Murphy BR, Whitehead SS: Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol 2005 May;79(9):5516-28.
7. Franchini G, Ambinder RF, Barry M. Viral disease in Hematology. Hematology Am Soc Hematol Educ Program 2000:409-423.
8. Balmaseda A, Hammond SN, Pérez L, Téllez Y, Saborio SI, Mercado JC, Cuadra R, Rocha J, Pérez MA, Silva S, Rocha C, Harris E: Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006 Mar;74(3):449-56.
9. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd Edition. Geneva; 1997.
10. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 2004 Oct;80(948):588-601.
11. Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, Thuy TT, Solomon T, Stepniewska K, Wills B; Dong Nai Study Group. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg 2004 Feb;70(2):172-9.
12. Mohan B, Patwari AK, Anand VK. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 2000 Feb;46(1):40-3.
13. Chen HC, Lai SY, Sung JM, Lee SH, Lin YC, Wang WK, Chen YC, Kao CL, King CC, Wu-Hsieh BA. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol 2004 Jul;73(3):419-31.
14. Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, Souto Filho JT, Cezario Tde A, Soares CE, Carneiro Rda C. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis 2004 Apr,8(2):156-63.
15. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK. Pharmaco-metabonomic phenotyping and personalized drugtreatment Nature 2006 Apr 20;440(7087):1073-7.
16. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992 Mar;30(3):545-51.
17. Kuno G, Gómez I, Gubler DJ. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 1991 Jun;33(1-2):101-13.
18. Jindadamrongwech S, Smith DR. Virus Overlay Protein Binding Assay (VOPBA) reveals serotype specific heterogeneity of dengue virus binding proteins on HepG2 human liver cells. Intervirology 2004 Nov-Dec;47(6):370-3.
19. Thepparit C, Smith DR. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 2004 Nov;78(22):12647-56.
20. Huerre MR, Lan NT, Marianneau P, Hue NB, Khun H, Hung NT, Khen NT, Drouet MT, Huong VT, Ha DQ, Buisson Y, Deubel V. Liver histopathotogy and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 2001 Feb;438(2):107-15.
21. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, Viramitrachai W, Ratanachu-eke S, Kiatpolpoj S, Innis BL, Rothman AL, Nisalak A, Ennis FA. J Infect Dis 1997 Aug;176(2):313-21.
22. Alcon-LePoder S, Drouet MT, Roux P, Frenkiel MP, Arborio M, Durand-Schneider AM, Maurice M, Le Blanc I, Gruenberg J, Flamand M. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol 2005 Sep;79(17):11403-11.